Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Eight functional polymorphisms in the estrogen receptor 1 gene and endometrial cancer risk: a meta-analysis.

Zhou X, Gu Y, Wang DN, Ni S, Yan J.

PLoS One. 2013 Apr 8;8(4):e60851. doi: 10.1371/journal.pone.0060851.

3.

Genetic polymorphisms in the estrogen receptor-α gene and the risk of endometrial cancer: a meta-analysis.

Wang Y, Cui M, Zheng L.

Acta Obstet Gynecol Scand. 2012 Aug;91(8):911-6. doi: 10.1111/j.1600-0412.2012.01393.x.

PMID:
22404101
4.

Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.

Gu Z, Wang G, Chen W.

Tumour Biol. 2014 Jun;35(6):5921-30. doi: 10.1007/s13277-014-1785-4.

PMID:
24584714
5.
6.

ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis.

Wang YM, Liu ZW, Guo JB, Wang XF, Zhao XX, Zheng X.

PLoS One. 2013 Jun 21;8(6):e66999. doi: 10.1371/journal.pone.0066999.

7.

Association between -251A>T polymorphism in the interleukin-8 gene and oral cancer risk: a meta-analysis.

Wang Z, Wang C, Zhao Z, Liu F, Guan X, Lin X, Zhang L.

Gene. 2013 Jun 15;522(2):168-76. doi: 10.1016/j.gene.2013.03.066.

PMID:
23545310
8.

Estrogen receptor-alpha gene PvuII (T/C) and XbaI (A/G) polymorphisms and endometriosis risk: a meta-analysis.

Li Y, Liu F, Tan SQ, Wang Y, Li SW.

Gene. 2012 Oct 15;508(1):41-8. doi: 10.1016/j.gene.2012.07.049.

PMID:
22890138
9.

Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis.

Cheng D, Liang B, Hao Y, Zhou W.

Clin Interv Aging. 2014 Jun 30;9:1031-8. doi: 10.2147/CIA.S65921.

10.

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Breast Cancer Res Treat. 2012 Dec;136(3):885-97. doi: 10.1007/s10549-012-2300-5. Review.

PMID:
23124475
11.

Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.

Gu Y, Zhou X, Zhang SL.

Genet Mol Res. 2011 Oct 31;10(4):3609-19. doi: 10.4238/2011.October.31.11.

12.
13.
14.
15.

Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.

Shen W, Li T, Hu Y, Liu H, Song M.

Gene. 2013 Dec 1;531(2):426-34. doi: 10.1016/j.gene.2013.08.072.

PMID:
23994294
16.

Association between estrogen receptor 1 (ESR1) genetic variations and cancer risk: a meta-analysis.

Sun H, Deng Q, Pan Y, He B, Ying H, Chen J, Liu X, Wang S.

J BUON. 2015 Jan-Feb;20(1):296-308. Review.

PMID:
25778331
17.

Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.

Wang F, Zou YF, Sun GP, Su H, Huang F.

Eur J Cancer Prev. 2011 Mar;20(2):112-20. doi: 10.1097/CEJ.0b013e3283410193.

PMID:
21191305
18.

Functional polymorphisms in microRNAs and susceptibility to liver cancer: a meta-analysis and meta-regression.

Wang BS, Liu Z, Xu WX, Sun SL.

Genet Mol Res. 2014 Jul 24;13(3):5426-40. doi: 10.4238/2014.July.24.22.

19.

Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.

Liu Y, Li L, Qi H, Gao Y, Liu S, Xu C.

PLoS One. 2013;8(2):e54081. doi: 10.1371/journal.pone.0054081. Review.

20.

Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Gene. 2012 Nov 15;510(1):71-7. doi: 10.1016/j.gene.2012.08.019.

PMID:
22940148
Items per page

Supplemental Content

Support Center